Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.

105 results found

Very late-onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation

Khan, SF; Yong, MK; Slavin, MA; Hughes, P; Sasadeusz, J

(2021), Transpl. Infect. Dis.

DOI: 10.1111/tid.13441

Hepatitis B related dilemmas in the renal unit

Holt, SG; Locarnini, S; Sasadeusz, J

(2021), Nephrology, 287-293

DOI: 10.1111/nep.13815

Misclassification of calcium status in end-stage kidney disease using albumin-adjusted calcium levels

Law, MM; Smith, JD; Schneider, HG; Wilson, S

(2021), Nephrology, 725-732

DOI: 10.1111/nep.13910

Operative experience in essential emergency general surgery procedures: is autonomy achievable during surgical training?

Belvedere, S; Joh, D; Furlong, T; Dennett, E; Loveday, BPT

(2021), ANZ J. Surg., 1131-1137

DOI: 10.1111/ans.16730

Proliferative Glomerulonephritis With Fibrils, Monoclonal kappa Light Chain, and C3 Deposits

Steinberg, AG; Fox, LC; Bender, S; Batrouney, A; Juneja, S; Sirac, C; Touchard, G; Blombery, P; Finlay, MJ; Bridoux, F; Barbour, TD

(2021), Am. J. Kidney Dis., 459-463

DOI: 10.1053/j.ajkd.2021.01.014

Transition from a renal paediatric clinic to an adult clinic: Perspectives of adolescents and young adults, parents and health professionals

Crawford, K; Low, JK; Le Page, AK; Mulley, W; Masterson, R; Kausman, J; Cook, N; Mount, P; Manias, E

(2021), J. Child Health Care

DOI: 10.1177/13674935211028410

Prolonged immunosuppression does not improve risk of sensitization or likelihood of retransplantation after kidney transplant graft failure

Martin, K; Cantwell, L; Barraclough, KA; Lian, M; Masterson, R; Hughes, PD; Chow, KV

(2021), Transpl. Int., 2353-2362

DOI: 10.1111/tri.13998

Paediatric deceased donor kidney transplant in Australia: A 30-year review-What have paediatric bonuses achieved and where to from here?

Sypek, MP; Davies, CE; Le Page, AK; Clayton, P; Hughes, PD; Larkins, N; Wong, G; Kausman, JY; Mackie, F

(2021), Pediatr. Transplant.

DOI: 10.1111/petr.14019

The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial

Bressendorff, I; Hansen, D; Pasch, A; Holt, SG; Schou, M; Brandi, L; Smith, ER

(2021), Nephrol. Dial. Transplant., 713-721

DOI: 10.1093/ndt/gfz234

The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis

Ruderman, I; Toussaint, ND; Hawley, CM; Krishnasamy, R; Pedagogos, E; Lioufas, N; Elder, GJ

(2021), Nephrol. Dial. Transplant., 649-656

DOI: 10.1093/ndt/gfz256

Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand

Tiong, MK; Ullah, S; McDonald, SP; Tan, SJ; Lioufas, NM; Roberts, MA; Toussaint, ND

(2021), Nephrology, 814-823

DOI: 10.1111/nep.13904

Incidence and predictors of vascular events following end-stage kidney disease in childhood

Le Page, AK; Kennedy, SE; Durkan, A; Chaturvedi, S; Walker, A; Sypek, MP

(2021), Nephrology, 715-724

DOI: 10.1111/nep.13886

Long-term follow-up of renal function in patients treated with migalastat for Fabry disease

Bichet, DG; Torra, R; Wallace, E; Hughes, D; Giugliani, R; Skuban, N; Krusinska, E; Feldt-Rasmussen, U; Schiffmann, R; Nicholls, K

(2021), Molec. Genet. Metab. Rep.

DOI: 10.1016/j.ymgmr.2021.100786

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus

Moreno-Martinez, D; Aguiar, P; Auray-Blais, C; Beck, M; Bichet, DG; Burlina, A; Cole, D; Elliott, P; Feldt-Rasmussen, U; Feriozzi, S; Fletcher, J; Giugliani, R; Jovanovic, A; Kampmann, C; Langeveld, M; Lidove, O; Linhart, A; Mauer, M; Moon, JC; Muir, A; Nowak, A; Oliveira, JP; Ortiz, A; Pintos-Morell, G; Politei, J; Rozenfeld, P; Schiffmann, R; Svarstad, E; Talbot, AS; Thomas, M; Tondel, C; Warnock, D; West, ML; Hughes, DA

(2021), Mol. Genet. Metab., 234-243

DOI: 10.1016/j.ymgme.2021.02.001

Electronic alerts for early detection of acute kidney injury: considering their implementation in Australian hospitals

Bendall, AC; Tan, SJ; See, EJ; Toussaint, ND

(2021), Med. J. Aust., 347

DOI: 10.5694/mja2.51024

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

Barbour, T; Scully, M; Ariceta, G; Cataland, S; Garlo, K; Heyne, N; Luque, Y; Menne, J; Miyakawa, Y; Yoon, SS; Kavanagh, D

(2021), Kidney Int. Rep., 1603-1613

DOI: 10.1016/j.ekir.2021.03.884

HLA Eplet Mismatches in Kidney Transplantation: More Than Just Adding Things Up

Sypek, MP; Hughes, P

(2021), Kidney Int. Rep., 1500-1502

DOI: 10.1016/j.ekir.2021.04.027

A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes

Hultin, S; Hood, C; Campbell, KL; Toussaint, ND; Johnson, DW; Badve, SV

(2021), Kidney Int. Rep., 695-705

DOI: 10.1016/j.ekir.2020.12.019

HBEGF: an EGF-like growth factor with FGF23-like activity?

Smith, ER; Hewitson, TD

(2021), Kidney Int., 539-542

DOI: 10.1016/j.kint.2020.11.011

Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease

Conley, M; Lioufas, N; Toussaint, ND; Elder, GJ; Badve, SV; Hawley, CM; Pascoe, EM; Pedagogos, E; Valks, A; Campbell, KL

(2021), J. Renal Nutr., 155-163

DOI: 10.1053/j.jrn.2020.02.007

A novel way to re-use reverse osmosis reject water

Agar, JWM; Barraclough, KA

(2021), J. Nephrol., 27-28

DOI: 10.1007/s40620-020-00924-9

Muddying the waters of hyperparathyroidism management in chronic kidney disease: a brown tumour in a predialysis patient

Tiong, MK; Yates, CJ; Toussaint, ND

(2021), Intern. Med. J., 450-451

DOI: 10.1111/imj.15235

Granulomatosis with polyangiitis complicated by genital involvement: sustained response to rituximab

Paxton, L; De Crespigny, PC; Nicholls, K

(2021), Intern. Med. J., 444-445

DOI: 10.1111/imj.15224

Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysis

Tiong, MK; Krishnasamy, R; Smith, ER; Hutchison, CA; Ryan, EG; Pascoe, EM; Hawley, CM; Hewitson, TD; Jardine, MJ; Roberts, MA; Cho, Y; Wong, MG; Heath, A; Nelson, CL; Sen, S; Mount, PF; Vergara, LA; Paul-Brent, PA; Johnson, DW; Toussaint, ND

(2021), Hemodial. Int., 322-332

DOI: 10.1111/hdi.12924

Clinical impact of genomic testing in patients with suspected monogenic kidney disease

Jayasinghe, K; Stark, Z; Kerr, PG; Gaff, C; Martyn, M; Whitlam, J; Creighton, B; Donaldson, E; Hunter, M; Jarmolowicz, A; Johnstone, L; Krzesinski, E; Lunke, S; Lynch, E; Nicholls, K; Patel, C; Prawer, Y; Ryan, J; See, EJ; Talbot, A; Trainer, A; Tytherleigh, R; Valente, G; Wallis, M; Wardrop, L; West, KH; White, SM; Wilkins, E; Mallett, AJ; Quinlan, C

(2021), Genet. Med., 183-191

DOI: 10.1038/s41436-020-00963-4

A Metabolic Reprogramming of Glycolysis and Glutamine Metabolism Is a Requisite for Renal Fibrogenesis-Why and How?

Hewitson, TD; Smith, ER

(2021), Front. Physiol.

DOI: 10.3389/fphys.2021.645857

Understanding factors contributing to the underrepresentation of female co-authors in intensive care publications

See, EJ; Lussier, S; Jones, D

(2021), Aust. Crit. Care, 519-521

DOI: 10.1016/j.aucc.2021.09.007

Inferiority of arteriovenous grafts, in comparison to autogenous fistulas, is underestimated by standard survival measures alone

Thwaites, SE; Holt, SG; Yii, MK

(2021), ANZ J. Surg., 162-167

DOI: 10.1111/ans.16472

First do no harm!

Robertson, A

(2021), ANZ J. Surg., 2571-2571

DOI: 10.1111/ans.17273

Addressing the Environmental Impact of Kidney Care

Yau, A; Agar, JWM; Barraclough, KA

(2021), Am. J. Kidney Dis., 406-409

DOI: 10.1053/j.ajkd.2020.09.011

1 2 3 4